Brief: Immunovia Q4 Net Sales Amounted To SEK 502,000
23/02/2023 07:41
Feb 23 (Reuters) - Immunovia AB (publ) IMMNOV.ST :
* Q4 NET SALES AMOUNTED TO TSEK 502 (305)
Source text for Eikon: ID:nWkr8llw58
Further company coverage: IMMNOV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Immunovia AB (publ)
See all newsBrief: Immunovia Publishes Data On Pancreasure In Hereditary, Familial High-Risk Individuals
Brief: Immunovia To Carry Out Rights Issue Of About SEK 63 Million
Sweden's Immunovia Q2 sales rise on PancreaSure test uptake
Brief: Immunovia Reports Q2 Operating Loss Of SEK 22.8 Million
Brief: PancreaSure Achieves 88% Sensitivity In Immunovia Study